Vedolizumab-treated CD Patients Undergoing Abdominal Surgery Vedolizumab-treated CD Patients Undergoing Abdominal Surgery
Biologic therapies are known to increase infection risk. How does vedolizumab impact the incidence of postoperative infectious complications among Crohn ' s disease patients?Alimentary Pharmacology & Therapeutics
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news
More News: Crohn's Disease | Drugs & Pharmacology | Gastroenterology | Health | Inflammatory Bowel Disease